Therapeutic Asset Ratings
414 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
kj015
Colorectal Cancer
Shanghai Bao Pharmaceuticals Co., Ltd.
P1
C
(36)
Kras Peptide Vaccine
Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1
C
(36)
Lm-Gucy2C Vaccine
Colorectal Cancer
Thomas Jefferson University
P1
C
(36)
LNTH-2403
Colorectal Cancer
Radiopharm Theranostics, Ltd
P1
C
(36)
[Lu-177]-Pnt6555
Colorectal Cancer
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company
P1
C
(36)
ly3962673
Colorectal Cancer
Eli Lilly and Company
P1
C
(36)
ly4066434.
Colorectal Cancer
Eli Lilly and Company
P1
C
(36)
lyl845
Colorectal Cancer
Lyell Immunopharma, Inc.
P1
C
(36)
ME 344
Colorectal Cancer
MEI Pharma, Inc.
P1
C
(36)
MGC026
Colorectal Cancer
MacroGenics
P1
C
(36)
MNPR-101-DFO-89Zr
Colorectal Cancer
Monopar Therapeutics
P1
C
(36)
Mnpr-101-Pcta-177Lu
Colorectal Cancer
Monopar Therapeutics
P1
C
(36)
Moma-341
Colorectal Cancer
MOMA Therapeutics
P1
C
(36)
mrg007
Colorectal Cancer
ArriVent BioPharma, Inc.
P1
C
(36)
ngm438
Colorectal Cancer
NGM Biopharmaceuticals, Inc
P1
C
(36)
nm1f
Colorectal Cancer
Hefei TG ImmunoPharma Co., Ltd.
P1
C
(36)
Ono-4538
Colorectal Cancer
Ono Pharmaceutical Co., Ltd.
P1
C
(36)
PANTOPRAZOLE
Colorectal Cancer
toqa saad mohammed mohammed
P1
C
(36)
Pepticrad-1
Colorectal Cancer
Valo Therapeutics Oy
P1
C
(36)
pf-07263689
Colorectal Cancer
Pfizer
P1
C
(36)
pf-07329640
Colorectal Cancer
Pfizer
P1
C
(36)
pf-07921585
Colorectal Cancer
Pfizer
P1
C
(36)
pf-08032562
Colorectal Cancer
Pfizer
P1
C
(36)
PIMITESPIB
Colorectal Cancer
Taiho Pharmaceutical Co., Ltd.
P1
C
(36)
PIN
Colorectal Cancer
Chinese PLA General Hospital
P1
C
(36)
Showing 326 to 350 of 414 assets
Previous
Page 14 of 17
Next